Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Poliovirus Receptor anticorps (C-Term)

PVR Reactivité: Humain WB Hôte: Lapin Polyclonal RB41981 unconjugated
N° du produit ABIN1881709
  • Antigène Voir toutes Poliovirus Receptor (PVR) Anticorps
    Poliovirus Receptor (PVR)
    Épitope
    • 13
    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 314-342, C-Term
    Reactivité
    • 54
    • 16
    • 5
    • 1
    Humain
    Hôte
    • 43
    • 12
    • 10
    Lapin
    Clonalité
    • 40
    • 24
    • 1
    Polyclonal
    Conjugué
    • 33
    • 6
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Poliovirus Receptor est non-conjugé
    Application
    • 34
    • 25
    • 20
    • 11
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This PVR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 314-342 amino acids from the C-terminal region of human PVR.
    Clone
    RB41981
    Isotype
    Ig Fraction
    Top Product
    Discover our top product PVR Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Nakai, Maniwa, Tanaka, Nishio, Yoshimura, Okita, Ohbayashi, Satoh, Ogita, Takai, Hayashi: "Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma." dans: Cancer science, Vol. 101, Issue 5, pp. 1326-30, (2010) (PubMed).

    Carlsten, Norell, Bryceson, Poschke, Schedvins, Ljunggren, Kiessling, Malmberg: "Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 183, Issue 8, pp. 4921-30, (2009) (PubMed).

    Kindberg, Ax, Fiore, Svensson: "Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis." dans: Journal of medical virology, Vol. 81, Issue 5, pp. 933-6, (2009) (PubMed).

  • Antigène
    Poliovirus Receptor (PVR)
    Autre désignation
    PVR (PVR Produits)
    Synonymes
    anticorps PVR, anticorps CD155, anticorps HVED, anticorps NECL5, anticorps Necl-5, anticorps PVS, anticorps TAGE4, anticorps 3830421F03Rik, anticorps D7Ertd458e, anticorps Taa1, anticorps Tage4, anticorps mE4, anticorps necl-5, anticorps poliovirus receptor, anticorps PVR, anticorps Pvr
    Sujet
    The protein encoded by this gene is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. The external domain mediates cell attachment to the extracellular matrix molecule vitronectin, while its intracellular domain interacts with the dynein light chain Tctex-1/DYNLT1. The gene is specific to the primate lineage, and serves as a cellular receptor for poliovirus in the first step of poliovirus replication. Multiple transcript variants encoding different isoforms have been found for this gene.
    Poids moléculaire
    45303
    NCBI Accession
    NP_001129240, NP_001129241, NP_001129242, NP_006496
    UniProt
    P15151
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome
Vous êtes ici:
Support technique